Thanks to some favorable news from the Food and Drug Administration (FDA) and more mergers and acquisitions activity, biotechnology stocks and exchange traded are shaking off their previously ...

Although the equities market often embodies chaos and capricious non-linearity, few sectors witness as much kinetic wildness like biotechnology. At its core, biotech represents an innovative push ...

There is no Morningstar’s Analysis data available.

LABU has the worst 1-year decay of this list with a drift of -13.56%. Over the last 12 months, the return of LABU (15.77%) is inferior to the return of the non-leveraged biotech index (18.82%). The ...

Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have ...

Over the past 12 months, LABU has changed by 91.75%, with its 52-week range spanning from 32.55 to 186.25. What Is the Daily Trading Range for LABU? The daily trading range for LABU has fluctuated ...